Intrinsic Value of S&P & Nasdaq Contact Us

Structure Therapeutics Inc. GPCR NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
59/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$116.71
+119.4%

Stock Statistics — GPCR

Structure Therapeutics Inc. (GPCR) has a market capitalization of $3.06B and trades at $53.19. The 52-week range is 13.22-94.9.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -22.2, Earnings Per Share (EPS) of $-2.40.

The stock has a beta of -1.25, operates in the Healthcare sector.

Trading Data
Current Price$53.19
52-Week Range13.22-94.9
Volume1.04M
Avg Volume (30D)1M
Market Cap$3.06B
Beta (1Y)-1.25
Company
IPO Date2023-02-03
Employees163
CEORaymond C. Stevens
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS86366E1064
CUSIP86366E106
Income (Latest Year)
Gross Profit$-3.9M
EBITDA$-136.79M
Operating Income$-287.57M
Net Income$-141.2M
EPS$-2.40
EPS Diluted$-2.40
Shares Outstanding$59.2M
Balance Sheet (Latest Year)
Total Assets$1.58B
Current Assets$1.57B
Cash & ST Investments$1.45B
Total Liabilities$67.54M
Total Debt$6.49M
Net Debt$-793.14M
Total Equity$1.52B
Debt / Equity0.00
Valuation Ratios
P/E Ratio-22.2
P/B Ratio2.02
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message